Executive Leadership

Driving continued growth, success and achievement

Chairman, President and Chief Executive Officer Image

Chairman, President and Chief Executive Officer

Brenton L. Saunders

Brent Saunders is Chairman of the Board of Directors, Chief Executive Officer and President of Allergan plc.

  • He previously served as Chief Executive Officer and President of Forest Laboratories and had served as a Director of Forest since 2011. Mr. Saunders has significant healthcare industry expertise and a proven track-record leading business transformations and integrations. Prior to Forest, he was chief executive officer of Bausch + Lomb, a leading global eye health company, serving in this capacity from March 2010 until August 2013. Mr. Saunders also held a number of leadership positions at Schering-Plough, including the position of president of Global Consumer Health Care and was named head of integration for the company’s merger with Merck & Co. and for Schering-Plough’s acquisition of Organon BioSciences. Before joining Schering-Plough, Mr. Saunders was a partner and head of Compliance Business Advisory at PricewaterhouseCoopers LLP. Prior to that, he was chief risk officer at Coventry Health Care and senior vice president, Compliance, Legal and Regulatory at Home Care Corporation of America. Mr. Saunders began his career as chief compliance officer for the Thomas Jefferson University Health System. Mr. Saunders serves on the Board of Directors at RWJBarnabas Health, and is a member of the Business Council and PhRMA. He is also the former Chairman of the New York chapter of the American Heart Association. Mr. Saunders, 46, earned his MBA from Temple University School of Business, his J.D. from Temple University School of Law and his bachelor’s degree from the University of Pittsburgh.

Chief Operating Officer Image

Chief Operating Officer

Robert Stewart

Bob Stewart was appointed Chief Operating Officer effective May 9, 2016.

  • Previously, Mr. Stewart served as President, Generics and Global Operations since March 2015; Chief Operating Officer of Actavis from July 2014 – March 2015; and President, Global Operations and Executive Vice President, Global Operations, from August 2010 – July 2014. He joined Actavis (then Watson) in November 2009 as Senior Vice President, Global Operations. Prior to joining Watson, Mr. Stewart held various positions with Abbott Laboratories, Inc. from 2002 until 2009 where he most recently served as Vice President, Global Supply Chain. From 2005 until 2008, he served as Divisional Vice President, Quality Assurance and prior to this position served as Divisional Vice President for U.S./Puerto Rico and Latin America Plant Operations as well as Director of Operations for Abbott’s Whippany plant. Prior to joining Abbott Laboratories, Inc., he worked for Knoll Pharmaceutical Company from 1995 to 2001 and Hoffman La-Roche Inc. Mr. Stewart received B.S. degrees in Business Management/Finance in 1994 from Fairleigh Dickinson University.

Chief Commercial Officer Image

Chief Commercial Officer

William Meury

Bill Meury was appointed Chief Commercial Officer effective May 9, 2016.

  • Previously, Mr. Meury served as President, Branded Pharma since March 2015. He joined Actavis in July 2014 as Executive Vice President, Commercial, North American Brands. Prior to joining Actavis, he served as Executive Vice President, Sales and Marketing, Forest Laboratories, Inc. He joined Forest in 1993 and held positions in Marketing, New Products, Business Development, and Sales. Most recently, as Executive Vice President, Sales and Marketing, Mr. Meury oversaw the activities of several departments including Product Management, Market Research, and Commercial Assessments, as well as Forest’s Global Marketing and Early Commercialization groups. Mr. Meury directed 10 product launches during his tenure at Forest. Before joining Forest, Mr. Meury worked in public accounting for Reznick Fedder & Silverman and in financial reporting for MCI Communications. He has a B.S. in Economics from the University of Maryland.

Chief R&D Officer Image

Chief R&D Officer

C. David Nicholson, PhD

David Nicholson was appointed head of Brand R&D effective March 17, 2015.

  • Dr. Nicholson joined Actavis as Senior Vice President, Global Brands R&D in August 2014. Previously, he served as Chief Technology Officer and EVP, R&D for Bayer CropScience from March 2012 to August 2014; Vice President of Licensing and Knowledge Management at Merck from 2009 to December 2011; and Senior Vice President, responsible for Global Project Management and Drug Safety at Schering-Plough from 2007 to 2009. From 1988 to 2007, Dr. Nicholson held various leadership positions at Organon, where he most recently served as Executive Vice President, Research & Development and was a member of the company’s Executive Management Committee. He received a B.Sc. from the University of Manchester and his Ph.D. from the University of Wales.

Chief Financial Officer Image

Chief Financial Officer

Maria Teresa Hilado

Maria Teresa (Tessa) Hilado was appointed Chief Financial Officer effective December 8, 2014.

  • Prior to joining the company, Ms. Hilado served as Senior Vice President, Finance and Treasurer for PepsiCo, Inc. since 2009. Before joining PepsiCo, she previously served as Vice President and Treasurer for Schering-Plough Corporation from 2008 to 2009. Before joining Schering-Plough, Ms. Hilado spent more than 17 years with General Motors Corporation in leadership roles of increasing responsibility, most notably Assistant Treasurer from 2006 to 2008 and CFO, GMAC Commercial Finance LLC from 2001 to 2005. She began her career with Far East Bank and Trust Company, Manila, Philippines. Ms. Hilado received a B.S. in Management Engineering from Ateneo de Manila University in the Philippines, and an MBA from the University of Virginia’s Darden School of Business Administration.

Chief Legal Officer and Corporate Secretary Image

Chief Legal Officer and Corporate Secretary

A. Robert D. Bailey

Bob Bailey was appointed Chief Legal Officer and Corporate Secretary effective July 1, 2014.

  • Previously, Mr. Bailey served as Senior Vice President, Chief Legal Officer, General Counsel and Corporate Secretary of Forest Laboratories, Inc. He previously served from 2007 to 2013 as Executive Vice President, Law, Policy and Communications at Bausch + Lomb. Before joining Bausch + Lomb in 1994, Mr. Bailey was an attorney at Nixon Peabody (formerly Nixon Hargrave Devans & Doyle). Mr. Bailey received his law degree from the University of Minnesota and his undergraduate degree from St. Olaf College in Northfield, MN.

Chief Human Resources Officer Image

Chief Human Resources Officer

Karen Ling

Karen Ling was appointed Chief Human Resources Officer effective July 1, 2014.

  • Prior to joining Actavis, Ms. Ling served as Senior Vice President and Chief Human Resources Officer for Forest Laboratories, Inc. Ms. Ling joined Forest in January 2014 from Merck & Co., Inc., where she served as Senior Vice President, Human Resources, for the company’s Global Human Health and Consumer Care businesses worldwide. Prior to that role at Merck, she was Vice President, Compensation and Benefits. Before Merck, Ms. Ling was Group Vice President, Global Compensation & Benefits at Schering-Plough. She also spent 14 years at Wyeth in various positions of responsibility in human resources as well as in Wyeth Pharmaceutical’s Labor and Employment Department. Prior to joining Wyeth, Ms. Ling practiced corporate law with Goldstein and Manello, P.C. in Boston. Ms. Ling holds a B.A. from Yale University and a J.D. from Boston University School of Law.

Chief Communications Officer Image

Chief Communications Officer

Alex Kelly

Alex Kelly was appointed Chief Communications Officer on April 20, 2015.

  • Previously, Mr. Kelly served as Senior Vice President, Chief Integration Officer since July 1, 2014. In this role, he led the integration of Forest Laboratories following its acquisition by Actavis. He also co-led the integration of Allergan. Prior to joining Actavis, Mr. Kelly was Senior Vice President, Chief Communications Officer, Public Affairs and Investor Relations at Forest Laboratories. In that role, he led Forest’s corporate communications and investor relations programs, including internal and external communications, media relations, corporate branding, product communications, and public affairs. While at Forest, Mr. Kelly led the integration of Aptalis Pharma following its acquisition in January 2014. Prior to Forest, Mr. Kelly served as Vice President, Investor Relations at Bausch + Lomb. Mr. Kelly was Senior Vice President, Investor Relations at Merck & Co., Inc. following the combination with Schering-Plough where he led the Global Communications and Investor Relations team. He previously worked for Novartis as Executive Director, Investor Relations, after spending 14 years at Pharmacia, including ten years in pharmaceutical sales and sales management and four years in investor relations. Mr. Kelly holds a Bachelor of Science in Pharmacy from Purdue University, where he graduated Cum Laude.

Contact Allergan
Morris Corporate Center III
400 interpace parkway
Parsippany, NJ 07054
+1 (862) 261-7000